Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma

Show other versions (1)

The purpose of this retrospective analysis is to analyze clinical outcome, visual acuity and enucleation rates after linear accelerator-based stereotactic fractionated photon radiotherapy for primary uveal melanoma.

Saved in:

Bibliographic Details
Main Authors:	Akbaba, Sati (Author) , Förster, Robert (Author) , Nicolay, Nils (Author) , Arians, Nathalie (Author) , Bostel, Tilman (Author) , Debus, Jürgen (Author) , Hauswald, Henrik (Author)
Format:	Article (Journal)
Language:	English
Published:	02 August 2018
In:	Radiation oncology Year: 2018, Volume: 13
ISSN:	1748-717X
DOI:	10.1186/s13014-018-1088-9
Online Access:	Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s13014-018-1088-9 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13014-018-1088-9
Author Notes:	Sati Akbaba, Robert Foerster, Nils Henrik Nicolay, Nathalie Arians, Tilman Bostel, Juergen Debus and Henrik Hauswald

Description
Summary:	The purpose of this retrospective analysis is to analyze clinical outcome, visual acuity and enucleation rates after linear accelerator-based stereotactic fractionated photon radiotherapy for primary uveal melanoma.
Item Description:	Gesehen am 08.08.2018
Physical Description:	Online Resource
ISSN:	1748-717X
DOI:	10.1186/s13014-018-1088-9